. 1989 Apr;7(2):97-101.
doi: 10.1016/0264-410x(89)90043-1. Anti-fertility vaccines G P Talwar 1
, R Raghupathy
Vaccines are under development for the control of fertility in males and females. This review discusses developments in anti-fertility vaccines at the National Institute of Immunology, New Delhi, India. A single injection procedure for the sterilization or castration of male animals depending on the site at which the injection is given, has passed through field testing and is expected to be on the market in the near future. Vaccines inducing antibodies against the human chorionic gonadotropin have gone through phase I trials with satisfactory results. A vaccine producing a consistently bioeffective antibody response against gonadotropin-releasing hormone is ready for phase I/II clinical trials in patients of carcinoma of prostate after due experimentation in animals and toxicology studies. Research to identify sperm antigens for incorporation into second generation vaccines is in progress. PIP:
Anti-fertility vaccine research carried out at the National Institute of Immunology in New Delhi, India is summarized. The vaccines react against follicle stimulating hormone (FSH), luteinizing hormone (LH), and gonadotropin releasing hormone (GnRH). Intratesticular injection of Bacillus Calmette-Guerin (BCG) in moderate concentrations causes the degeneration of the blood-testes barrier, which finally leads to reversible azoospermia and it is suited for use in animals. Anti-hCG (anti-human chorionic gonadotropin) vaccines include beta-hCG linked to tetanus toxoid /TT (beta-hCG-TT) the alpha-subunit of ovine LH associated with beta-hCG and linked to TT or cholera toxin chain b (CHB/alpha-oLH, beta-hCG-TT/CHB/, the mixture of hCG and oLH, and 37 amino acid carboxy-terminal peptide (CTP) of beta-hCG linked to diphtheria toxoid (DT). The principle of anti-hCG vaccine is to induce antibodies which can bind to hCG and render it biologically inactive. The beta-subunit of hCG has proven efficacious in controlling fertility, and similarly 36 amino acid CTP was effective in baboons. The beta-hCG- TT vaccine evoked the production of anti-hCG antibodies in 61 of 63 women tested. The mixture of beta-hCG and beta-ovine LH conjugated to TT or CHB /formulation M/ and beta-hCG annealed to alpha-ovine LH and conjugated to TT or to CHB (formulation A/ produced improved) immunogenicity. Immunization with GnRH resulted in decreased testicular size, drop of testosterone levels, and marked atrophy of the prostate. Anti-GnRH vaccine would be tried in patients of carcinoma of the prostate. LDH-C4, a sperm-specific mitochondrial antigen, produced an antibody response in baboons and reduced fertility in the females. Animal fertility control vaccines will be shortly on the market, but the use of recombinant DNA techniques should also accelerate the development of others.
- Vaccines for control of fertility and hormone dependent cancers.
Talwar GP, Singh O, Pal R, Chatterjee N. Int J Immunopharmacol. 1992 Apr;14(3):511-4. doi: 10.1016/0192-0561(92)90183-l. PMID: 1618603 Review.
- Enhancement of antigonadotropin response to the beta-subunit of ovine luteinizing hormone by carrier conjugation and combination with the beta-subunit of human chorionic gonadotropin.
Talwar GP, Singh O, Singh V, Rao DN, Sharma NC, Das C, Rao LV. Fertil Steril. 1986 Jul;46(1):120-6. doi: 10.1016/s0015-0282(16)49469-0. PMID: 2424791
- Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
Thau R. Scand J Immunol Suppl. 1992;11:127-30. doi: 10.1111/j.1365-3083.1992.tb01635.x. PMID: 1514027
Jones WR. Baillieres Clin Obstet Gynaecol. 1992 Sep;6(3):629-40. doi: 10.1016/s0950-3552(05)80014-8. PMID: 1446424 Review.
- Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin.
Singh O, Rao LV, Gaur A, Sharma NC, Alam A, Talwar GP. Fertil Steril. 1989 Nov;52(5):739-44. PMID: 2806615
See all similar articles